First Light Asset Management’s Maravai LifeSciences MRVI Stock Holding History

First Light Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-96,637	Closed	-$4.05M	–	77
2021 Q4	$4.05M	Sell	96,637 -22,066	-19%	-$894K	0.29%	50
2021 Q3	$5.83M	Sell	118,703 -83,435	-41%	-$4.07M	0.38%	48
2021 Q2	$8.44M	Sell	202,138 -288,911	-59%	-$11.2M	0.51%	45
2021 Q1	$17.5M	Buy	491,049 +122,849	+33%	+$4.07M	1.16%	32
2020 Q4	$10.3M	Buy	+368,200	New	+$10.3M	0.76%	32

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Light Asset Management's MRVI Position: Q1 2022 in Review

First Light Asset Management sold out of Maravai LifeSciences (MRVI) in Q1 2022, closing a stake of 96,637 shares — an estimated $4.05M sold.

First Light Asset Management first reported a position in MRVI in Q4 2020 and held it in 5 quarters. The position peaked at $17.5M in Q1 2021. 235 funds tracked by Wall St. Rank hold MRVI as of Q1 2022.

First Light Asset Management reported no remaining Maravai LifeSciences position as of Q1 2022 after selling out during the quarter.
First Light Asset Management sold 96,637 Maravai LifeSciences shares in Q1 2022, an estimated $4.05M.
First Light Asset Management first reported a position in Maravai LifeSciences in Q4 2020 and held it in 5 quarters.
First Light Asset Management's Maravai LifeSciences position peaked at $17.5M in Q1 2021.
235 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2022.

Based on First Light Asset Management's 13F filing for Q1 2022, filed 13 May 2022.